Increasing antibiotic resistance in bacteria causing endogenous infections has entailed a
need for innovative approaches to therapy and prophylaxis of these infections and raised a …

Abstract Purpose of Review There have been recent advances in our understanding of
cutaneous immune responses to the important human skin pathogen, Staphylococcus …

Background Staphylococcus aureus is an opportunistic pathogen and a leading cause of
nosocomial infections. It can acquire resistance to all the antibiotics that entered the clinics …

Introduction: Case-fatality rates for Staphylococcus aureus bacteremia (SAB) remain
unacceptably high and have improved only modestly in recent decades. Treatment of SAB is …

Staphylococcus aureus (S. aureus) produces a wide variety of toxins that cause various
diseases in humans. S. aureus toxins are divided into three categories;(i) superantigens …

A key aspect underlying the severity of infections caused by Staphylococcus aureus is the
abundance of virulence factors that the pathogen uses to thwart critical components of the …

Purpose We previously reported that monoclonal antibody (mAb) cocktail improves survival
in Staphylococcus aureus infection. In this study, we used acute pneumonia model and …

Background An essential fact underlying the severity of Staphylococcus aureus (S. aureus)
infection is the bicomponent leukocidins released by the pathogen to target and lyse host …

Drug-resistant Staphylococcus aureus (DRSA) poses a significant global health threat, like
bacteremia, endocarditis, skin, soft tissue, bone, and joint infections. Nowadays, the …

Staphylococci are the main cause of nosocomial infections globally. The exotoxin
staphylococcal enterotoxin B (SEB) produced by methicillin-resistant Staphylococcus aureus …